MENU

Why these 4 ASX shares are ending the week with a bang

In afternoon trade the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is on course to finish the day in the red. At the time of writing the index is down 0.3% to 6,334.9 points.

Four shares that have defied the market and pushed higher today are listed below. Here’s why they are ending the week with a bang:

The Blue Sky Alternative Investments Ltd (ASX: BLA) share price has rebounded from yesterday’s heavy decline and jumped almost 10.5% to $1.80. Yesterday Blue Sky announced its full year results which revealed a 63% decline in underlying revenue to $24.9 million. This led to the embattled asset manager reporting an underlying net loss after tax of $85.6 million. Some investors may have thought yesterday’s selloff was a buying opportunity.

The Freedom Foods Group Ltd (ASX: FNP) share price has stormed 14% higher to $6.67 after the healthy foods company released its full year results after the market closed on Thursday. Freedom Foods reported annual net sales growth of 34.5% to $353 million and operating net profit growth of 96.9% to $19.4 million. Looking ahead, management held firm with its FY 2019 net sales guidance in the range of $500 million to $530 million.

The Starpharma Holdings Limited (ASX: SPL) share price has surged 12% higher $1.29. This morning the developer of dendrimer products advised that AstraZeneca’s first patent application on DEP Bcl2/xL conjugates has been published by the World Intellectual Property Organisation. These DEP conjugates combine Starpharma’s innovative DEP delivery technology with AstraZeneca’s novel inhibitor for treating various cancers, including leukemias. The results show compelling efficacy and synergy in combination.

The Zenitas Healthcare Ltd (ASX: ZNT) share price has rocketed almost 23% higher to $1.42 after the home care roll up advised that it has received a takeover approach from a consortium comprising Adamantem Capital and Liverpool Partners. The consortium has offered $1.46 per share in cash, which looks like a good deal for shareholders.

OUR #1 dividend pick to grow your wealth now is revealed for FREE here!

You might not know this market leader's name, but it's rapidly expanding into a highly profitable niche market here in Australia. Even better, the shares boast a strong, fully franked dividend that should balloon in the years to come. In other words, we're looking at the holy grail of incredible long-term growth potential AND income you can watch accruing in your account in real time!

Simply click here to grab your FREE copy of this up-to-the-minute research report on our #1 dividend share recommendation now.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Freedom Foods Group Limited and Zenitas Healthcare Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!